Page 2 - Greg Zante News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Greg zante. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Greg Zante Today - Breaking & Trending Today

Viking Therapeutics (NASDAQ:VKTX) Rating Increased to Strong-Buy at Raymond James

Raymond James upgraded shares of Viking Therapeutics (NASDAQ:VKTX – Free Report) from an outperform rating to a strong-buy rating in a research note published on Thursday morning, MarketBeat.com reports. Raymond James currently has $116.00 price objective on the biotechnology company’s stock, up from their previous price objective of $115.00. VKTX has been the topic of […] ....

Marianna Mancini , Raymond James , Greg Zante , Securities Exchange Commission , Therapeutics Inc , Jefferies Financial Group , Massmutual Trust Co , Maxim Group , Lindbrook Capital , Wetzel Investment Advisors Inc , Therapeutics Company Profile , Lifesteps Financial Inc , Viking Therapeutics , Free Report , Moderate Buy , Get Free Report , Exchange Commission , Investment Advisors , Steps Financial , Spire Wealth Management , Viking Therapeutics Daily ,

Viking Therapeutics, Inc. (NASDAQ:VKTX) Receives Average Recommendation of "Buy" from Brokerages

Viking Therapeutics, Inc. (NASDAQ:VKTX) Receives Average Recommendation of "Buy" from Brokerages
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Marianna Mancini , Greg Zante , Raymond James , Therapeutics Inc , Jefferies Financial Group , Wetzel Investment Advisors Inc , Maxim Group , Lifesteps Financial Inc , Lindbrook Capital , Massmutual Trust Co , Therapeutics Company Profile , Viking Therapeutics , Get Free Report , Marketbeat Ratings , Financial Group , Investment Advisors , Steps Financial , Spire Wealth Management , Get Free , Viking Therapeutics Daily ,

E Fund Management Co. Ltd. Sells 6,582 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)

E Fund Management Co. Ltd. Sells 6,582 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Marianna Mancini , Greg Zante , Fund Management Co , Allspring Global Investments Holdings , Therapeutics Company Profile , Exchange Commission , E Fund Management Co , Wealth Management , Corton Capital Inc , Therapeutics Inc , Wetzel Investment Advisors Inc , Jefferies Financial Group , Viking Therapeutics , Free Report , Fund Management , Investment Advisors , Global Investments Holdings , Aigen Investment Management , Financial Group , Get Free Report , Viking Therapeutics Daily ,

Viking Therapeutics, Inc. (NASDAQ:VKTX) Receives $112.25 Consensus Target Price from Analysts

Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) have received a consensus recommendation of “Buy” from the ten research firms that are presently covering the stock, Marketbeat reports. Ten equities research analysts have rated the stock with a buy recommendation. The average 12-month price target among brokers that have updated their coverage on […] ....

United States , William Blair , Stifel Nicolaus , Greg Zante , Marianna Mancini , Therapeutics Company Profile , Deerfield Management Companylp Series , Vanguard Group Inc , Jefferies Financial Group , American Century Companies Inc , Goldman Sachs Group Inc , Securities Exchange Commission , Maxim Group , Therapeutics Inc , Viking Therapeutics , Get Free Report , Financial Group , Exchange Commission , Century Companies , Goldman Sachs Group , Sachs Group , Get Free , Viking Therapeutics Daily ,

Viking Therapeutics, Inc. (NASDAQ:VKTX) CFO Sells $4,986,005.64 in Stock

Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) CFO Greg Zante sold 66,756 shares of the stock in a transaction dated Friday, May 3rd. The shares were sold at an average price of $74.69, for a total value of $4,986,005.64. Following the completion of the sale, the chief financial officer now owns 174,854 shares of […] ....

United States , Stifel Nicolaus , Raymond James , Greg Zante , Therapeutics Company Profile , Goldman Sachs Group Inc , Massachusetts Financial Services Co , Charles Schwab Investment Management Inc , Therapeutics Inc , Maxim Group , Securities Exchange Commission , American Century Companies Inc , Viking Therapeutics , Get Free Report , Exchange Commission , Century Companies , Financial Services , Sachs Group , Charles Schwab Investment Management , Schwab Investment Management , Viking Therapeutics Daily , Nasdaq Vktx , Insider Trading , Nsider Trades ,